Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
about
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Pemetrexed Disodium With or Wi ...... IV Non-Small Cell Lung Cancer
@en
type
label
Pemetrexed Disodium With or Wi ...... IV Non-Small Cell Lung Cancer
@en
prefLabel
Pemetrexed Disodium With or Wi ...... IV Non-Small Cell Lung Cancer
@en
P4844
P6153
P1476
Phase II Randomized Study of P ...... ced Non-Small Cell Lung Cancer
@en
P3098
NCT00454194
P580
2007-09-01T00:00:00Z
P582
2010-07-01T00:00:00Z